MDxHealth SA (MDXH) Financial Statements — Income, Balance Sheet, Cash Flow

Overview Financials Chart Business Summary Filings Ownership Valuation

Financial Statements — MDXH

Balance Sheet

(in millions USD)

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Cash & Equivalents	29.03	46.80	22.38	15.50	58.50
Inventory	6.74	3.87	2.78	2.33	1.91
Total Current Assets	53.41	66.90	38.16	29.15	66.61
Goodwill	38.95	35.93	35.93	35.93	1.15
Total Non-current Assets	94.54	90.43	90.97	89.99	8.47
Total Assets	147.95	157.33	129.13	119.14	75.07
Total Current Liabilities	49.53	42.66	19.52	18.28	16.43
Total Non-current Liabilities	110.51	99.83	102.40	91.54	11.74
Total Liabilities	160.05	142.49	121.92	109.82	28.17
Retained Earnings	(403.03)	(369.51)	(331.45)	(288.35)	(244.30)
Total Stockholder Equity	(12.09)	14.84	7.21	9.32	46.90

Income Statement

(in billions USD) (except per-share rows)

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	0.11	0.09	0.07	0.04	0.02
Cost of Revenue*	0.04	0.03	0.03	0.02	0.01
Gross Profit	0.07	0.06	0.04	0.02	0.01
Research & Development	0.01	0.01	0.01	0.01	0.01
Selling, General & Admin	0.03	0.02	0.02	0.02	0.01
Total Operating Expenses*	0.08	0.08	0.00	0.00	5.89
Operating Income	(0.01)	(0.02)	(0.03)	(0.04)	(0.03)
Interest Expense	0.00	0.00	0.00	0.00	0.00
Pretax Income	(0.04)	(0.04)	(0.04)	(0.04)	(0.03)
Tax Provision	-0.00	0.00	0.00	0.00	0.00
Net Income	(0.03)	(0.04)	(0.04)	(0.04)	(0.03)
Basic EPS	(0.67)	(1.16)	(1.66)	(0.28)	(0.24)
Diluted EPS	(0.67)	(1.16)	1.66	0.28	(0.24)

* Derived from reported values

Cash Flow Statement

(in millions USD)

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Operating Cash Flow	(2.19)	(18.53)	(21.50)	(34.12)	(22.55)
Investing Cash Flow	(18.56)	(1.64)	(3.93)	(29.16)	(0.88)
Financing Cash Flow	2.97	44.60	32.28	20.84	66.50